Grandview Asset Management LLC Bio N Tech Se Transaction History
Grandview Asset Management LLC
- $175 Million
- Q3 2024
Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
324Shares Held
39.1MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.31MShares$922 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$531 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$486 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$325 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$210 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $26.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...